e-learning
resources
Breathe
2020
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
In defence of extrapolation but not improvisation in SARS-CoV-2 lung disease
Oleg Epelbaum, Irene Galperin
Source:
Breathe, 16 (2) 200113; 10.1183/20734735.0113-2020
Journal Issue:
June
Disease area:
Respiratory critical care
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Oleg Epelbaum, Irene Galperin. In defence of extrapolation but not improvisation in SARS-CoV-2 lung disease. Breathe, 16 (2) 200113; 10.1183/20734735.0113-2020
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Indications and pitfalls of high-flow nasal cannula (HFNC) outside the intensive care unit
Inflammatory biomarkers are associated with aetiology and predict outcomes in community-acquired pneumonia: results of a 5-year follow-up cohort study
Related content which might interest you:
The environment, epigenetics and lung disease
Source: Annual Congress 2013 –PG6 Epigenetics of asthma and COPD
Year: 2013
Host–microbe cross-talk in the lung microenvironment: implications for understanding and treating chronic lung disease
Source: Eur Respir J, 56 (2) 1902320; 10.1183/13993003.02320-2019
Year: 2020
Determinants of lung cancer evolution: immune escape and inflammation
Source: International Congress 2018 – Scientific Year in Review
Year: 2018
Personalising airway clearance in chronic lung disease
Source: Eur Respir Rev 2017; 26: 160086
Year: 2017
Local immune protection mechanisms during bacterial infection of the airways in patients with interstitial lung diseases
Source: Annual Congress 2009 - Mechanisms of infection: what's new?
Year: 2009
The adaptive immune system, autoimmunity and COPD: lessons from human studies
Source: Annual Congress 2007 - T- and B-cells in COPD: a role for adaptive immunity in the pathogenesis of COPD?
Year: 2007
Immunology and defence mechanism of the developing lung
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-50-2, page=60
Year: 2006
The estimation of adaptation of functional systems of the patients with a lung cancer and secondary inflammatory changes
Source: Eur Respir J 2006; 28: Suppl. 50, 751s
Year: 2006
The integrated stress response in lung disease
Source: International Congress 2015 – Dysfunctional protein quality control in paediatric and adult lung diseases
Year: 2015
The time-controlled adaptive ventilation protocol: mechanistic approach to reducing ventilator-induced lung injury
Source: Eur Respir Rev, 28 (152) 180126; 10.1183/16000617.0126-2018
Year: 2019
The adaptive immune system, autoimmunity and COPD: lessons from animal models
Source: Annual Congress 2007 - T- and B-cells in COPD: a role for adaptive immunity in the pathogenesis of COPD?
Year: 2007
From ineffective tumor immune response to immunomodulation in lung cancer
Source: ERS Research Seminar 2017 – Immunotherapy: a new standard of care in thoracic malignancies?
Year: 2017
Pulmonary defence mechanisms and inflammatory pathways in bronchiectasis
Source: Eur Respir Mon 2011; 52: 11-21
Year: 2011
Siphonage lung disease
Source: Virtual Congress 2020 – Respiratory critical care
Year: 2020
Ageing of the immune system: a contribution to lung disease?
Source: Annual Congress 2012 - Searching for the secrets of senescence in the lung
Year: 2012
Control of lung defence by mucins and macrophages: ancient defence mechanisms with modern functions
Source: Eur Respir J 2016; 48: 1201-1214
Year: 2016
Pivotal role of the HMGB1/sRAGE axis in drug-induced lung injury in advanced lung cancer with pre-existing interstitial lung disease
Source: Virtual Congress 2020 – Addressing unresolved questions in rare diffuse parenchymal lung diseases: interdisciplinary research is the key
Year: 2020
Angiogenesis in lung development, injury and repair: implications for chronic lung disease of prematurity
Source: Annual Congress 2008 - Physiological year in review
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept